$WAT
WATERS CORP /DE/

2012 Q3 Form 10-Q Financial Statement

#000119312512448069 Filed on November 02, 2012

View on sec.gov

Income Statement

Concept 2012 Q3
Revenue $450.0M
YoY Change 0.52%
Cost Of Revenue $182.7M
YoY Change 3.75%
Gross Profit $267.3M
YoY Change -1.57%
Gross Profit Margin 59.4%
Selling, General & Admin $115.3M
YoY Change -8.07%
% of Gross Profit 43.15%
Research & Development $23.76M
YoY Change 3.22%
% of Gross Profit 8.89%
Depreciation & Amortization $20.60M
YoY Change 19.08%
% of Gross Profit 7.71%
Operating Expenses $139.1M
YoY Change -6.32%
Operating Profit $121.7M
YoY Change 0.98%
Interest Expense $7.107M
YoY Change 40.68%
% of Operating Profit 5.84%
Other Income/Expense, Net
YoY Change
Pretax Income $115.8M
YoY Change -0.43%
Income Tax $16.71M
% Of Pretax Income 14.43%
Net Earnings $99.10M
YoY Change -1.0%
Net Earnings / Revenue 22.02%
Basic Earnings Per Share
Diluted Earnings Per Share $1.120M
COMMON SHARES
Basic Shares Outstanding 87.41M shares
Diluted Shares Outstanding 88.45M shares

Balance Sheet

Concept 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.448B
YoY Change 29.13%
Cash & Equivalents $356.3M
Short-Term Investments $1.092B
Other Short-Term Assets $79.69M
YoY Change 14.14%
Inventory $247.0M
Prepaid Expenses
Receivables $362.4M
Other Receivables $0.00
Total Short-Term Assets $2.137B
YoY Change 18.75%
LONG-TERM ASSETS
Property, Plant & Equipment $261.1M
YoY Change 19.43%
Goodwill $316.3M
YoY Change 7.57%
Intangibles $212.9M
YoY Change 9.12%
Long-Term Investments
YoY Change
Other Assets $69.39M
YoY Change 8.22%
Total Long-Term Assets $859.6M
YoY Change 11.37%
TOTAL ASSETS
Total Short-Term Assets $2.137B
Total Long-Term Assets $859.6M
Total Assets $2.997B
YoY Change 16.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $60.26M
YoY Change -11.34%
Accrued Expenses $39.80M
YoY Change -10.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $447.7M
YoY Change 228.71%
Total Short-Term Liabilities $767.6M
YoY Change 64.26%
LONG-TERM LIABILITIES
Long-Term Debt $700.0M
YoY Change 0.0%
Other Long-Term Liabilities $33.16M
YoY Change 32.62%
Total Long-Term Liabilities $899.7M
YoY Change 2.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $767.6M
Total Long-Term Liabilities $899.7M
Total Liabilities $1.667B
YoY Change 23.84%
SHAREHOLDERS EQUITY
Retained Earnings $3.337B
YoY Change 18.62%
Common Stock $1.138B
YoY Change 9.08%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.116B
YoY Change 16.98%
Treasury Stock Shares 66.59M shares
Shareholders Equity $1.330B
YoY Change
Total Liabilities & Shareholders Equity $2.997B
YoY Change 16.54%

Cashflow Statement

Concept 2012 Q3
OPERATING ACTIVITIES
Net Income $99.10M
YoY Change -1.0%
Depreciation, Depletion And Amortization $20.60M
YoY Change 19.08%
Cash From Operating Activities $101.3M
YoY Change 4.22%
INVESTING ACTIVITIES
Capital Expenditures -$26.10M
YoY Change 41.08%
Acquisitions
YoY Change
Other Investing Activities -$82.00M
YoY Change 137.68%
Cash From Investing Activities -$108.2M
YoY Change 104.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -16.90M
YoY Change -750.0%
NET CHANGE
Cash From Operating Activities 101.3M
Cash From Investing Activities -108.2M
Cash From Financing Activities -16.90M
Net Change In Cash -23.80M
YoY Change -150.85%
FREE CASH FLOW
Cash From Operating Activities $101.3M
Capital Expenditures -$26.10M
Free Cash Flow $127.4M
YoY Change 10.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
WATERS CORP /DE/
dei Entity Central Index Key
EntityCentralIndexKey
0001000697
dei Document Type
DocumentType
10-Q
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Period End Date
DocumentPeriodEndDate
2012-09-29
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2012Q3 dei Entity Public Float
EntityPublicFloat
6966563351 USD
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
86954060 shares
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
356293000 USD
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
362371000 USD
CY2012Q3 us-gaap Inventory Net
InventoryNet
246994000 USD
CY2012Q3 us-gaap Other Assets Current
OtherAssetsCurrent
79692000 USD
CY2012Q3 us-gaap Assets Current
AssetsCurrent
2137498000 USD
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
261115000 USD
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
212870000 USD
CY2012Q3 us-gaap Goodwill
Goodwill
316269000 USD
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
69388000 USD
CY2012Q3 us-gaap Assets
Assets
2997140000 USD
CY2012Q3 us-gaap Debt Current
DebtCurrent
447703000 USD
CY2011Q4 us-gaap Debt Current
DebtCurrent
290832000 USD
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
60258000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
55317000 USD
CY2012Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26964000 USD
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
49949000 USD
CY2012Q3 us-gaap Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
128072000 USD
CY2011Q4 us-gaap Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
109922000 USD
CY2012Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
20711000 USD
CY2011Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
9449000 USD
CY2012Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12885000 USD
CY2011Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
13258000 USD
CY2012Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
70969000 USD
CY2011Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
73136000 USD
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
767562000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
601863000 USD
CY2012Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
700000000 USD
CY2011Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
700000000 USD
CY2012Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
96201000 USD
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
92970000 USD
CY2012Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
70343000 USD
CY2011Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
72613000 USD
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33155000 USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29210000 USD
CY2012Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
899699000 USD
CY2011Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
894793000 USD
CY2012Q3 us-gaap Liabilities
Liabilities
1667261000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
1496656000 USD
CY2012Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
1535000 USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
1528000 USD
CY2012Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1136473000 USD
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1089959000 USD
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3336946000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3051447000 USD
CY2012Q3 us-gaap Treasury Stock Value
TreasuryStockValue
3115583000 USD
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2880301000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-29492000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-36055000 USD
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
1329879000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
1226578000 USD
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2997140000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2723234000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
383990000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
367085000 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
212864000 USD
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
80804000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
1942104000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
237095000 USD
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
191992000 USD
CY2011Q4 us-gaap Goodwill
Goodwill
297071000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
54972000 USD
CY2011Q4 us-gaap Assets
Assets
2723234000 USD
CY2012Q3 wat Allowances For Doubtful Accounts And Sales Returns
AllowancesForDoubtfulAccountsAndSalesReturns
7616000 USD
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
153512000 shares
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86926000 shares
CY2012Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
66586000 shares
CY2011Q4 wat Allowances For Doubtful Accounts And Sales Returns
AllowancesForDoubtfulAccountsAndSalesReturns
8584000 USD
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
152757000 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
88996000 shares
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
63761000 shares
CY2012Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1448000000 USD
CY2011Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1281000000 USD
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
99109000 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
267250000 USD
CY2012Q3 us-gaap Cost Of Services
CostOfServices
59841000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23756000 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
122861000 USD
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1184000 USD
CY2012Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
182702000 USD
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
449952000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
115822000 USD
CY2012Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
139129000 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
115322000 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
7107000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
121745000 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
310823000 USD
CY2012Q3 wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
6427000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16713000 USD
CY2011Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23372000 USD
CY2011Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
124228000 USD
CY2011Q4 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
133186000 USD
CY2011Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
121211000 USD
CY2011Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
180318000 USD
CY2011Q4 us-gaap Gross Profit
GrossProfit
274216000 USD
CY2011Q4 us-gaap Interest Expense
InterestExpense
6159000 USD
CY2011Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
613000 USD
CY2011Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
121718000 USD
CY2011Q4 us-gaap Sales Revenue Net
SalesRevenueNet
454534000 USD
CY2011Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
101257000 USD
CY2011Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20461000 USD
CY2011Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
321348000 USD
CY2011Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
127264000 USD
CY2011Q4 us-gaap Cost Of Services
CostOfServices
56090000 USD
CY2011Q4 wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
2369000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.13
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.12
CY2011Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.10
CY2011Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.12
CY2011Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90688000 shares
CY2011Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
92060000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87411000 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88451000 shares
CY2012Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.144 pure
CY2011Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.168 pure
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
911185000 USD
CY2011Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-31741000 USD
CY2012Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
23936000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
10312000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
9811000 USD
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-5000 USD
CY2011Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-2547000 USD
us-gaap Interest Expense
InterestExpense
15294000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2139000 USD
wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
11370000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.147 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.156 pure
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-3000000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
410690000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
1321875000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
352894000 USD
us-gaap Cost Of Services
CostOfServices
176357000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
529251000 USD
us-gaap Gross Profit
GrossProfit
792624000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
355123000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71046000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
352085000 USD
us-gaap Interest Expense
InterestExpense
20476000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2984000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
334593000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49094000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
285499000 USD
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
3.24
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88234000 shares
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
3.19
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89367000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
92898000 shares
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
3.18
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91334000 shares
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
3.24
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
295821000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54750000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
350571000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
363726000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
68640000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
363774000 USD
us-gaap Gross Profit
GrossProfit
803514000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
526250000 USD
us-gaap Cost Of Services
CostOfServices
164841000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
361409000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
1329764000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
388930000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
940834000 USD
wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
7374000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1010000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-18000 USD
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1000 USD
CY2011Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-891000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-351000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-6000 USD
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4000 USD
CY2011Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1656000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-659000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
783000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
115428000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
558199000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
352676000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Tax
OtherComprehensiveIncomeDefinedBenefitPlansTax
383000 USD
CY2012Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease
165000 USD
CY2011Q4 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease
119000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1384717000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1189930000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-298851000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
188074000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-12000 USD
CY2012Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Tax
OtherComprehensiveIncomeDefinedBenefitPlansTax
89000 USD
CY2011Q4 us-gaap Other Comprehensive Income Defined Benefit Plans Tax
OtherComprehensiveIncomeDefinedBenefitPlansTax
64000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Tax
OtherComprehensiveIncomeDefinedBenefitPlansTax
-1760000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease
-2589000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease
712000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
24097000 USD
CY2011Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
-33278000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
6563000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
11012000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
123206000 USD
CY2011Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
67979000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
292062000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
306833000 USD
CY2012Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPeriodIncreaseDecrease
254000 USD
CY2011Q4 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPeriodIncreaseDecrease
183000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPeriodIncreaseDecrease
-4349000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPeriodIncreaseDecrease
1095000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1838000 USD
us-gaap Inventory Write Down
InventoryWriteDown
8334000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
21687000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9382000 USD
us-gaap Depreciation
Depreciation
27101000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24124000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5506000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
36558000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2959000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
811000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-18971000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-3998000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
317627000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
73048000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
31935000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
497000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
21284000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
235282000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4061000 USD
us-gaap Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
-899000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-53396000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
6923000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-27697000 USD
us-gaap Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
1971000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-37953000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
45687000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
297985000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-194714000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4523000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1297497000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
51344000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11937000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
4782000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
347312000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10040000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
46235000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4532000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4023000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2267000 USD
us-gaap Inventory Write Down
InventoryWriteDown
7477000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
20645000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7072000 USD
us-gaap Depreciation
Depreciation
27267000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22778000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
308498000 USD
us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
16217000 USD
us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
20970000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1165127000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
15316000 USD
CY2012Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11000000 USD
CY2011Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
31016000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
423926000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
11000000 USD
us-gaap Nature Of Operations
NatureOfOperations
<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Waters Corporation (&#8220;Waters</font><font style="font-family:Times New Roman;font-size:10pt;">&#174;</font><font style="font-family:Times New Roman;font-size:10pt;">&#8221; or the &#8220;Company&#8221;) is</font><font style="font-family:Times New Roman;font-size:10pt;"> an analytical instrument manufacturer</font><font style="font-family:Times New Roman;font-size:10pt;"> that</font><font style="font-family:Times New Roman;font-size:10pt;"> primarily designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography (&#8220;HPLC&#8221;), ultra performance liquid chromatography (&#8220;UPLC</font><font style="font-family:Times New Roman;font-size:10pt;">&#174;</font><font style="font-family:Times New Roman;font-size:10pt;">&#8221; and together with HPLC, referred to as &#8220;LC&#8221;) and mass spectrometry (&#8220;MS&#8221;) </font><font style="font-family:Times New Roman;font-size:10pt;">technology </font><font style="font-family:Times New Roman;font-size:10pt;">systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. These systems are complementary products that </font><font style="font-family:Times New Roman;font-size:10pt;">are frequently employed </font><font style="font-family:Times New Roman;font-size:10pt;">together</font><font style="font-family:Times New Roman;font-size:10pt;"> (&#8220;LC-MS&#8221;)</font><font style="font-family:Times New Roman;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;">sold as integrated instrument systems using a common software platform and are used along with other </font><font style="font-family:Times New Roman;font-size:10pt;">analytical instruments. LC is a standard technique and is utilized in a broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a full range of compounds. MS instruments are used in drug discovery and development, including clinical trial testing, the analysis of proteins in disease processes (known as &#8220;proteomics&#8221;), food safety analysis and environmental testing. LC</font><font style="font-family:Times New Roman;font-size:10pt;">-MS</font><font style="font-family:Times New Roman;font-size:10pt;"> instruments </font><font style="font-family:Times New Roman;font-size:10pt;">combine </font><font style="font-family:Times New Roman;font-size:10pt;">a liquid phase sample introduction and separation system with mass spectrometric compound identification and quantification. Through its TA Division (&#8220;TA</font><font style="font-family:Times New Roman;font-size:10pt;">&#174;</font><font style="font-family:Times New Roman;font-size:10pt;">&#8221;), the Company primarily designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments, which are used in predicting the suitability of fine chemicals, polymers and viscous liquids for various industrial, consumer goods and healthcare products, as well as for life science research. The Company is also a developer and supplier of software-based products that interface with the Company's instruments and are typically purchased by customers as part of the instrument system.</font></p>
us-gaap Additional Cash And Cash Equivalent Related Text
AdditionalCashAndCashEquivalentRelatedText
The Company&#8217;s cash equivalents primarily represent highly liquid investments, with original maturities of 90&#160;days or less, primarily in bank deposits, U.S. and U.K. treasury bill money market funds and commercial paper.
CY2012Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
108987000 USD
CY2012Q3 us-gaap Short Term Investments
ShortTermInvestments
1092148000 USD
CY2012Q3 wat Waters Restoration Plan Assets
WatersRestorationPlanAssets
24243000 USD
CY2012Q3 us-gaap Foreign Currency Fair Value Hedge Asset At Fair Value
ForeignCurrencyFairValueHedgeAssetAtFairValue
146000 USD
CY2012Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1225524000 USD
CY2012Q3 us-gaap Foreign Currency Fair Value Hedge Liability At Fair Value
ForeignCurrencyFairValueHedgeLiabilityAtFairValue
531000 USD
CY2012Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
531000 USD
CY2011Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
142966000 USD
CY2011Q4 us-gaap Short Term Investments
ShortTermInvestments
897361000 USD
CY2011Q4 wat Waters Restoration Plan Assets
WatersRestorationPlanAssets
20667000 USD
CY2011Q4 us-gaap Foreign Currency Fair Value Hedge Asset At Fair Value
ForeignCurrencyFairValueHedgeAssetAtFairValue
81000 USD
CY2011Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1061075000 USD
CY2011Q4 us-gaap Foreign Currency Fair Value Hedge Liability At Fair Value
ForeignCurrencyFairValueHedgeLiabilityAtFairValue
1317000 USD
CY2011Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1317000 USD
CY2012Q3 us-gaap Notional Amount Of Foreign Currency Fair Value Hedge Derivatives
NotionalAmountOfForeignCurrencyFairValueHedgeDerivatives
133000000 USD
CY2011Q4 us-gaap Notional Amount Of Foreign Currency Fair Value Hedge Derivatives
NotionalAmountOfForeignCurrencyFairValueHedgeDerivatives
161000000 USD
CY2012Q3 us-gaap Maturity Of Foreign Currency Derivatives
MaturityOfForeignCurrencyDerivatives
The periods of these forward contracts typically range from one to three months and have varying notional amounts, which are intended to be consistent with changes in the underlying exposures.
wat Cumulative Net Pre Tax Gains Losses On Forward Foreign Exchange Contracts
CumulativeNetPreTaxGainsLossesOnForwardForeignExchangeContracts
-1659000 USD
us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
-1971000 USD
us-gaap Change In Unrealized Gain Loss On Foreign Currency Fair Value Hedging Instruments
ChangeInUnrealizedGainLossOnForeignCurrencyFairValueHedgingInstruments
312000 USD
CY2012Q3 wat Cumulative Net Pre Tax Gains Losses On Forward Foreign Exchange Contracts
CumulativeNetPreTaxGainsLossesOnForwardForeignExchangeContracts
1017000 USD
CY2012Q3 us-gaap Change In Unrealized Gain Loss On Foreign Currency Fair Value Hedging Instruments
ChangeInUnrealizedGainLossOnForeignCurrencyFairValueHedgingInstruments
593000 USD
CY2012Q3 us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
424000 USD
CY2011Q4 wat Cumulative Net Pre Tax Gains Losses On Forward Foreign Exchange Contracts
CumulativeNetPreTaxGainsLossesOnForwardForeignExchangeContracts
-3781000 USD
CY2011Q4 us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
-3941000 USD
CY2011Q4 us-gaap Change In Unrealized Gain Loss On Foreign Currency Fair Value Hedging Instruments
ChangeInUnrealizedGainLossOnForeignCurrencyFairValueHedgingInstruments
160000 USD
us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
899000 USD
wat Cumulative Net Pre Tax Gains Losses On Forward Foreign Exchange Contracts
CumulativeNetPreTaxGainsLossesOnForwardForeignExchangeContracts
1750000 USD
us-gaap Change In Unrealized Gain Loss On Foreign Currency Fair Value Hedging Instruments
ChangeInUnrealizedGainLossOnForeignCurrencyFairValueHedgingInstruments
851000 USD
CY2011Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
128578000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
5780000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-6153000 USD
CY2011Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12496000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
7061000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-5837000 USD
CY2010Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11272000 USD
CY2012Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
75288000 USD
CY2012Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
19118000 USD
CY2012Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
152588000 USD
CY2011Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
71993000 USD
CY2011Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12293000 USD
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Assets Acquired
BusinessAcquisitionPurchasePriceAllocationAssetsAcquired
40446000 USD
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Current Assets Inventory
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsInventory
2887000 USD
CY2012Q3 us-gaap Business Acquisition Cost Of Acquired Entity Cash Paid
BusinessAcquisitionCostOfAcquiredEntityCashPaid
32164000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
263534000 USD
CY2012Q3 wat Business Acquisition Purchase Price Allocation Other Assets
BusinessAcquisitionPurchasePriceAllocationOtherAssets
412000 USD
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Current Liabilities
BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities
2896000 USD
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Property Plant And Equipment
BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment
1254000 USD
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Noncurrent Liabilities Long Term Debt
BusinessAcquisitionPurchasePriceAllocationNoncurrentLiabilitiesLongTermDebt
732000 USD
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Deferred Income Taxes Asset Liability Net
BusinessAcquisitionPurchasePriceAllocationDeferredIncomeTaxesAssetLiabilityNet
4654000 USD
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Goodwill Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillAmount
18460000 USD
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Amortizable Intangible Assets
BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets
15966000 USD
wat Expected Incremental Annual Sales From Acquired Entity
ExpectedIncrementalAnnualSalesFromAcquiredEntity
10000000 USD
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Current Assets Receivables
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsReceivables
319000 USD
CY2012Q3 us-gaap Business Acquisition Purchase Price Allocation Current Assets Cash And Cash Equivalents
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents
1148000 USD
CY2012Q3 wat Intangible Assets Gross
IntangibleAssetsGross
476404000 USD
CY2011Q4 wat Intangible Assets Gross
IntangibleAssetsGross
431675000 USD
CY2011Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
239683000 USD
us-gaap Finite Lived Intangible Assets Average Useful Life
FiniteLivedIntangibleAssetsAverageUsefulLife
7 pure
CY2011 us-gaap Finite Lived Intangible Assets Average Useful Life
FiniteLivedIntangibleAssetsAverageUsefulLife
7 pure
wat Intangible Assets Gross Foreign Currency Translation Adjustments
IntangibleAssetsGrossForeignCurrencyTranslationAdjustments
-1000000 USD
us-gaap Future Amortization Expense Year One
FutureAmortizationExpenseYearOne
43000000 USD
us-gaap Future Amortization Expense Year Two
FutureAmortizationExpenseYearTwo
43000000 USD
us-gaap Future Amortization Expense Year Three
FutureAmortizationExpenseYearThree
43000000 USD
us-gaap Future Amortization Expense Year Four
FutureAmortizationExpenseYearFour
43000000 USD
us-gaap Future Amortization Expense Year Five
FutureAmortizationExpenseYearFive
43000000 USD
us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
1000000 USD
CY2012Q3 wat Debt
Debt
1147703000 USD
CY2011Q4 wat Debt
Debt
990832000 USD
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
73199000 USD
CY2010Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
71523000 USD
CY2012Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
71258000 USD
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
73008000 USD
wat Change In Other Uncertain Tax Benefits
ChangeInOtherUncertainTaxBenefits
-1941000 USD
wat Change In Other Uncertain Tax Benefits
ChangeInOtherUncertainTaxBenefits
1485000 USD
CY2012Q3 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
-5000000 USD
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7306000 USD
CY2011Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6882000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21687000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20645000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
32000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
6 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
32000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
6 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.021 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.380 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.290 pure
wat Weighted Average Exercise Price Of Options Granted
WeightedAverageExercisePriceOfOptionsGranted
75.94
wat Weighted Average Exercise Price Of Options Granted
WeightedAverageExercisePriceOfOptionsGranted
78.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
28.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
25.25
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1300000 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1300000 shares
CY2011Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000 shares
CY2011Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1372000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1133000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1564000 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4809000 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
-464000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-68000 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4309000 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
56.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
64.71
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
58.68
CY2012Q3 wat Exercise Price Range Of Options Outstanding Lower Range Limit
ExercisePriceRangeOfOptionsOutstandingLowerRangeLimit
21.39
CY2012Q3 wat Exercise Price Range Of Options Outstanding Upper Range Limit
ExercisePriceRangeOfOptionsOutstandingUpperRangeLimit
79.15
CY2011Q4 wat Exercise Price Range Of Options Outstanding Lower Range Limit
ExercisePriceRangeOfOptionsOutstandingLowerRangeLimit
21.39
CY2011Q4 wat Exercise Price Range Of Options Outstanding Upper Range Limit
ExercisePriceRangeOfOptionsOutstandingUpperRangeLimit
79.15
wat Exercise Price Range Of Options Exercised Lower Range Limit
ExercisePriceRangeOfOptionsExercisedLowerRangeLimit
21.39
wat Exercise Price Range Of Options Exercised Upper Range Limit
ExercisePriceRangeOfOptionsExercisedUpperRangeLimit
79.05
wat Exercise Price Range Of Options Canceled Lower Range Limit
ExercisePriceRangeOfOptionsCanceledLowerRangeLimit
41.20
wat Exercise Price Range Of Options Canceled Upper Range Limit
ExercisePriceRangeOfOptionsCanceledUpperRangeLimit
77.94
wat Weighted Average Exercise Price Of Options Exercised
WeightedAverageExercisePriceOfOptionsExercised
38.57
CY2012Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1040000 shares
wat Estimated Total Employer Contributions To Defined Benefit Plans In Current Fiscal Year Lower Range
EstimatedTotalEmployerContributionsToDefinedBenefitPlansInCurrentFiscalYearLowerRange
7000000 USD
wat Estimated Total Employer Contributions To Defined Benefit Plans In Current Fiscal Year Higher Range
EstimatedTotalEmployerContributionsToDefinedBenefitPlansInCurrentFiscalYearHigherRange
9000000 USD

Files In Submission

Name View Source Status
0001193125-12-448069-index-headers.html Edgar Link pending
0001193125-12-448069-index.html Edgar Link pending
0001193125-12-448069.txt Edgar Link pending
0001193125-12-448069-xbrl.zip Edgar Link pending
d426002d10q.htm Edgar Link pending
d426002dex1035.htm Edgar Link pending
d426002dex311.htm Edgar Link pending
d426002dex312.htm Edgar Link pending
d426002dex321.htm Edgar Link pending
d426002dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wat-20120929.xml Edgar Link completed
wat-20120929.xsd Edgar Link pending
wat-20120929_cal.xml Edgar Link unprocessable
wat-20120929_def.xml Edgar Link unprocessable
wat-20120929_lab.xml Edgar Link unprocessable
wat-20120929_pre.xml Edgar Link unprocessable